Evidence map›Paper›PMID 38961406›Full record

ArticleAlzheimer's research & therapy2024

Choroid plexus volume as a novel candidate neuroimaging marker of the Alzheimer's continuum.

Jiwei Jiang, Zhizheng Zhuo, Anxin Wang, Wenyi Li, Shirui Jiang, Yunyun Duan, Qiwei Ren, Min Zhao, Linlin Wang, Shiyi Yang and 3 more

Abstract read
In one paragraph

Article in Alzheimer's research & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Choroid plexus volume in pathology-confirmed Alzheimer's disease.The journal of prevention of Alzheimer's disease · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Unveiling the glymphatic system's role in brain aging: A comprehensive biomarker and modifiable intervention target.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  15. Article
  16. Article
  17. Choroidal-ventricular system abnormalities are linked to amyloid-β aggregation in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jiwei JiangBeijing Tiantan Hospital, Capital Medical University, Beijing, China.
Zhizheng ZhuoBeijing Tiantan Hospital, Capital Medical University, Beijing, China.
Anxin WangBeijing Tiantan Hospital, Capital Medical University, Beijing, China.
Wenyi LiBeijing Tiantan Hospital, Capital Medical University, Beijing, China.
Shirui JiangBeijing Tiantan Hospital, Capital Medical University, Beijing, China.
Yunyun DuanBeijing Tiantan Hospital, Capital Medical University, Beijing, China.
Qiwei RenBeijing Tiantan Hospital, Capital Medical University, Beijing, China.
Min ZhaoBeijing Tiantan Hospital, Capital Medical University, Beijing, China.
Linlin WangBeijing Tiantan Hospital, Capital Medical University, Beijing, China.
Shiyi YangBeijing Tiantan Hospital, Capital Medical University, Beijing, China.
Maher Un Nisa AwanThe Affiliated Hospital of Yunnan University, Kunming, China.
Yaou LiuBeijing Tiantan Hospital, Capital Medical University, Beijing, China. liuyaou@bjtth.org.
Jun XuBeijing Tiantan Hospital, Capital Medical University, Beijing, China. neurojun@126.com.

Funding

National Key Research and Development Program of China 2021YFC2500100 and 2021YFC2500103National Natural Science Foundation of China 82071187 and 81870821
6 · The paper itself

Abstract

backgroundEnlarged choroid plexus (ChP) volume has been reported in patients with Alzheimer's disease (AD) and inversely correlated with cognitive performance. However, its clinical diagnostic and predictive value, and mechanisms by which ChP impacts the AD continuum remain unclear.

methodsThis prospective cohort study enrolled 607 participants [healthy control (HC): 110, mild cognitive impairment (MCI): 269, AD dementia: 228] from the Chinese Imaging, Biomarkers, and Lifestyle study between January 1, 2021, and December 31, 2022. Of the 497 patients on the AD continuum, 138 underwent lumbar puncture for cerebrospinal fluid (CSF) hallmark testing. The relationships between ChP volume and CSF pathological hallmarks (Aβ

resultsThe participants' mean age was 65.99 ± 8.79 years. Patients with AD dementia exhibited the largest baseline ChP volume than the other groups (P < 0.05). ChP volume enlargement correlated with decreased Aβ

conclusionsChP volume may be a novel neuroimaging marker associated with neurodegenerative changes and clinical AD manifestations. It could better detect the early stages of the AD and predict prognosis, and significantly enhance the differential diagnostic ability of hippocampus on the AD continuum.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesBiomarkersChoroid PlexusCognitive DysfunctionNeuroimagingAgedFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNeuropsychological TestsPeptide FragmentsProspective Studiestau ProteinsAmyloid beta-PeptidesBiomarkersPeptide Fragmentstau ProteinsAlzheimer’s diseaseAmyloid-betaChoroid plexusLongitudinal studiesMediation analysisROC curve

Identifiers

PMID38961406
PMCPMC11221040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.